Details
European Medicines Agency is a decentralised agency of the European Union based in Amsterdam, responsible for the scientific evaluation, supervision, and safety monitoring of medicines for both human and veterinary use across the EU and EEA. It plays a central role in ensuring that medicines placed on the European market are safe, effective, and of high quality, supporting public health across a population of hundreds of millions.
The agency coordinates a network of scientific committees and experts from member states who assess applications for marketing authorisations, particularly for innovative and high-impact medicines such as biologics, vaccines, and advanced therapies. Once a medicine is approved through EMA’s centralised procedure, it can be marketed across all EU countries.
Beyond approvals, EMA also monitors safety throughout a medicine’s lifecycle, issues scientific guidance, and supports innovation in pharmaceutical development. It is increasingly involved in sustainability and modernisation efforts within pharmaceutical manufacturing and regulation.